Tectonic Therapeutic (TECX) Net Cash Flow (2017 - 2026)

Tectonic Therapeutic (TECX) has 10 years of Net Cash Flow data on file, last reported at -$17.6 million in Q1 2026.

• On a quarterly basis, Net Cash Flow fell 110.66% year-over-year to -$17.6 million in Q1 2026; TTM through Mar 2026 was -$69.5 million, a 124.16% decrease from a year earlier, with the FY2025 full-year figure at $113.1 million, up 0.59% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$17.6 million, down from -$14.6 million in the prior quarter.
• Over the last five years, Net Cash Flow for TECX reached as high as $166.4 million in Q2 2024 and fell as low as -$29.3 million in Q2 2022.
• Historically, Net Cash Flow has averaged $6.1 million across 5 years, with a median of -$17.6 million in 2026.
• Across the five-year window, Net Cash Flow plunged 343.98% in 2022 and surged 20973.27% in 2024, its largest moves.
• Year by year, Net Cash Flow stood at -$23.6 million in 2022, then surged by 194.96% to $22.4 million in 2023, then slumped by 179.8% to -$17.9 million in 2024, then climbed by 18.39% to -$14.6 million in 2025, then retreated by 20.43% to -$17.6 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$17.6 million in Q1 2026, -$14.6 million in Q4 2025, and -$18.4 million in Q3 2025.